["{\n\"step_by_step_thinking\": \"The question is about combining antiretroviral agents. In the relevant document 'Current status of HIV therapy: I. Antiretroviral agents', it mentions the combination of zidovudine and ddC has been approved on the basis of surrogate marker activity. This suggests that combining antiretroviral agents can have a positive effect. Additionally, in another document 'Polypharmacy: dangers of multiple-drug therapy in patients with human immunodeficiency virus infection', it highlights the importance of knowledge of potential drug interactions and systematic assessment tools to meet the challenges of polypharmacy. This implies that combining antiretroviral agents can be beneficial if done correctly.\",\n\"answer_choice\": A"]